Mayo Clinic

儿童同样面临COVID-19的长期影响

Newswise — 罗切斯特,明尼苏达州 ― COVID-19感染可能对部分儿童和青少年,以及成人的健康产生长期影响。虽然大多数COVID-19儿童感染者症状轻微或根本没有症状,但对于任何COVID-19感染者而言,即使病情轻微或没有症状,感染也可能产生长期影响。

长期COVID-19或长期症状患者是指COVID-19感染者的一个亚群。他们不是在感染后的几周内康复,而是长期存在症状,通常持续数周甚至数月,”妙佑医疗国际(Mayo Clinic)儿科传染病医生Nipunie Rajapakse(医学博士)说道。

“不是每个人都会发生这种情况,”Rajapakse博士解释说,“我们正试图了解为什么只是部分而不是所有患者都会发生这种情况。”

业界已经就此现象展开一些研究。例如,美国国家卫生研究院正在研究COVID-19对儿童的影响,包括儿童感染者的长期结果。

“我们已经做了很多努力,首先是想办法识别这些患者,并找出我们可以帮助他们的最佳方法,”Rajapakse博士说,“出现这些症状的患者即便可以回到学校、回到工作岗位、回到他们可能参加过的运动项目,可能也很难恢复到以前的身体机能水平。”

“长期COVID-19带来的真正挑战之一在于,它不是一种状况或一组症状,”Rajapakse博士说,“患者自述的症状五花八门,如严重疲劳、肌肉酸痛、疼痛、喉咙痛、发热、呼吸困难,每个人几乎都有这些症状的独特组合。这些症状可能持续不同的时间,并且严重程度各异。”

长期COVID-19症状可能包括:

  • 困倦或疲劳。
  • 难以思考或集中注意力(有时称为“脑雾”)。
  • 头痛。
  • 嗅觉或味觉丧失。
  • 站立时头晕。

部分人出现长期COVID-19症状的原因或频率尚不清楚。这些症状也可能与许多其他慢性疾病的症状重叠,因此必须进行全面的医学评估,以确保不是其他医学问题导致症状。

“至于为什么会出现这些症状?是由于病毒本身对某些器官系统的影响,或者更多的是由于免疫系统的影响及其对感染的反应?人们目前尚存有很多疑问。造成这种情况的原因可能有很多,”Rajapakse博士说,“但我认为最初的工作重点是想办法识别这些患者,把他们送到可以帮助他们的医疗机构,并设法了解导致出现这种情况的根本原因。”

关于妙佑医疗国际(Mayo Clinic) 妙佑医疗国际是一所致力于创新并集临床实践、医学教育和科学研究为一体的非营利机构,以恻隐之心竭诚提供精湛医术和解决方案给需要治疗的每个人。请访问妙佑医疗国际新闻网,取得更多妙佑医疗国际的新闻信息。关于COVID-19的详情,包括妙佑医疗国际的冠状病毒分布图追踪工具含有的14天COVID-19趋势预报,请访问妙佑医疗国际COVID-19资源中心

媒体联系:

请联系妙佑医疗国际媒体关系部:Sharon Theimer。邮箱:[email protected]



Filters close

Showing results

110 of 5857
Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Newswise: First Wave COVID-19 Data Underestimated Pandemic Infections
18-Jun-2021 8:30 AM EDT
First Wave COVID-19 Data Underestimated Pandemic Infections
American Institute of Physics (AIP)

Two COVID-19 pandemic curves emerged within many cities during the one-year period from March 2020 to March 2021. Oddly, the number of total daily infections reported during the first wave is much lower than that of the second, but the total number of daily deaths reported during the first wave is much higher than the second wave.

Newswise: PNNL AI Expert Harnesses Open-Source Data to Understand Human Behavior
Released: 22-Jun-2021 9:55 AM EDT
PNNL AI Expert Harnesses Open-Source Data to Understand Human Behavior
Pacific Northwest National Laboratory

PNNL researchers used natural language processing and deep learning techniques to reveal how and why different types of misinformation and disinformation spread across social platforms. Applied to COVID-19, the team found that misinformation intended to influence politics and incite fear spreads fastest.

Released: 22-Jun-2021 8:30 AM EDT
Engineering Nanobodies As Lifesavers When SARS-CoV-2 Variants Attack
Ohio State University

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

Released: 21-Jun-2021 3:45 PM EDT
Rare Neurological Disorder Documented Following COVID-19 Vaccination
American Neurological Association (ANA)

In two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barré syndrome after individuals were vaccinated against COVID-19.

Newswise: New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic
17-Jun-2021 12:10 PM EDT
New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic
Harvard Medical School

Risk of SARS-CoV-2 infection increased 30 percent for households with a recent birthday in counties with high rates of COVID-19 Findings suggest informal social gatherings such as birthday parties played role in infection spread at the height of the coronavirus pandemic No birthday-bash infection jumps seen in areas with low rates of COVID-19 Households with children’s birthdays had greater risk of SARS-CoV-2 infection than with adult birthdays

Newswise: COVID-19 dual-antibody therapies effective against variants in animal study
Released: 21-Jun-2021 10:05 AM EDT
COVID-19 dual-antibody therapies effective against variants in animal study
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis suggests that many, but not all, COVID-19 therapies made from combinations of two antibodies are effective against a wide range of virus variants, and that combination therapies appear to prevent the emergence of drug resistance.


Showing results

110 of 5857

close
1.44472